Tag: Regulatory & Policy

Africa CDC condemns Canada’s decision to deny entry to unvaccinated travelers

Frank

AFRICA – The Africa Centers for Disease Control and Prevention (Africa CDC) has criticized a move by Canada to block international travelers who have not had a COVID-19 vaccine jab from entering its borders. The agency’s head warned that the decision would widen inequalities, as most low-income countries continue to struggle to obtain the vital jabs. “AfricaCDC warned that this scenario was imminent once some countries have vaccinated a substantial portion of their population. This decision by Canada will further exacerbate inequities and make it harder to win the global…

Read More

Rwanda tightens restriction measures, including school closure, as Uganda approves Covidex

Frank

RWANDA – Rwanda has announced a review of COVID-19 restriction measures due to a surge in cases and the emergence of new variants globally. Schools and higher education institutions in the country will be closed. Provisions for students sitting national exams in July 2021 will be communicated by the ministry of education. Movements in some parts of the country has also prohibited between 6 pm-4 am and businesses conditioned to close by 5 pm. Social gatherings including gatherings held in homes and family visits are prohibited. All meetings have The…

Read More

Joseph Biden’s administration pumps in US$3.2bn for the development of a COVID-19 drug

Frank

US – The US government is taking another leap into the fight against COVID-19 through an investment worth US$3.2 billion to help develop antiviral therapy pills. This is part of the American Rescue Plan (ARP) government strategy to develop the next generation of COVID-19 treatments. ARP was developed to provide emergency grants, lending, and investment to hard-hit small businesses during the pandemic. This plan will provide more than $300 million for research and lab support, nearly $1 billion for preclinical and clinical evaluation, and nearly $700 million for development and…

Read More

German legislature approves legislation that will expedite access to life-changing cell and gene therapies

Frank

GERMANY-The German parliament, the Bundestag, has approved a legislation that would enable patients have greater access to new transformative cell and gene therapies. The legislation will address a bureaucratic barrier that delayed the availabilities of new and innovative drugs, medical devices and procedures (NUB) to patients. In order to be able to integrate new examination and treatment methods into the G-DRG system, the NUB request procedure was first introduced in Germany in 2005. For this purpose, NUB requests (InEK) would only be made once in a year with the extra…

Read More